TRPA1 and glioblastoma: Conversely, stimulating TRPA1-mediated Ca2+ entry could represent a valuable tool to sensitize ROS-dependent cytosolic Ca2+ overload and apoptosis in OSCC, glioblastoma, and colorectal carcinoma.